43.73
-0.03
(-0.08%)
As of 8:00:13 AM GMT+2. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
92,603,000
95,159,000
96,820,000
109,314,000
Total Liabilities Net Minority Interest
76,215,000
65,674,000
65,702,000
73,308,000
Total Equity Gross Minority Interest
16,388,000
29,485,000
31,118,000
36,006,000
Total Capitalization
63,938,000
66,083,000
66,117,000
75,551,000
Common Stock Equity
16,335,000
29,430,000
31,061,000
35,946,000
Capital Lease Obligations
1,551,000
1,692,000
1,397,000
1,043,000
Net Tangible Assets
-29,027,000
-19,224,000
-26,443,000
-27,331,000
Working Capital
6,006,000
9,508,000
5,383,000
11,394,000
Invested Capital
65,984,000
69,202,000
70,381,000
80,499,000
Tangible Book Value
-29,027,000
-19,224,000
-26,443,000
-27,331,000
Total Debt
51,200,000
41,464,000
40,717,000
45,596,000
Net Debt
39,303,000
28,308,000
30,197,000
30,574,000
Share Issued
2,923,000
2,923,000
2,900,000
2,900,000
Ordinary Shares Number
2,029,000
2,021,000
2,075,000
2,153,000
Preferred Shares Number
3.48
3.48
3.48
3.48
Treasury Shares Number
894,000
902,000
825,000
747,000
12/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MRK.MX Merck & Co., Inc.
1,560.00
-2.80%
NOTA.BE Novartis AG
97.40
+3.18%
NOV.MU Novo Nordisk A/S
55.89
+0.47%
SNW.HM Sanofi SA
91.01
+1.03%
PFE.CL Pfizer Inc.
95,280.00
-2.60%
4AB.F AbbVie Inc.
151.60
-0.79%
NOTA.DU Novartis AG
96.00
-0.83%
BAYZF Bayer Aktiengesellschaft
23.65
0.00%
GLAXO.BO GlaxoSmithKline Pharmaceuticals Limited
2,896.00
-1.11%
NOVA.F Novo Nordisk A/S
56.30
+3.30%